California Institute for Regenerative Medicine: Stem Cell Agency Board Approves Three More Projects Targeting COVID-19
May 30, 2020
May 30, 2020
OAKLAND, California, May 30 -- The California Institute for Regenerative Medicine issued the following news release on May 29:
The COVID-19 virus targets many different parts of the body, often with deadly or life-threatening consequences. That's why the governing Board of the California Institute for Regenerative Medicine (CIRM) approved investments in three early-stage research programs taking different approaches to battling the virus.
Dr. Jianhua Yu at the Beckman R . . .
The COVID-19 virus targets many different parts of the body, often with deadly or life-threatening consequences. That's why the governing Board of the California Institute for Regenerative Medicine (CIRM) approved investments in three early-stage research programs taking different approaches to battling the virus.
Dr. Jianhua Yu at the Beckman R . . .